Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas
10.1007/s00018-020-03620-w
Saved in:
Main Authors: | Jeitany, Maya, Prabhu, Aishvaryaa, Dakle, Pushkar, Pathak, Elina, Madan, Vikas, Kanojia, Deepika, Mukundan, Vineeth, Jiang, Yan Yi, Landesman, Yosef, Tam, Wai Leong, Kappei, Dennis, Koeffler, H. Phillip |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Springer Science and Business Media Deutschland GmbH
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232246 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A systematic review of margin status in retroperitoneal liposarcomas: does the R0 margin matter?
by: Paik, Benjamin, et al.
Published: (2022) -
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
by: CHEN YE, et al.
Published: (2021) -
Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival
by: Lee, D.H., et al.
Published: (2016) -
Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma
by: Garg, M, et al.
Published: (2020) -
Genomic landscape of liposarcoma
by: Kanojia, D, et al.
Published: (2020)